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LETTERS TO EDITOR 
the most disturbed psychotics from the 
desperately helpless and poor families is not in 
tune with the great humane traditions of 
Psychiatry. 
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THE SURREPTITIOUS ADMINISTRATION OF 
CLOZAPINE: CRITICAL ISSUES 
Sir. 
Clozapine is a useful drug for 
schizophrenic patients who do not respond to 
other medications; however, such patients are 
often poorly compliant with treatment regimes. 
We present a situation in which family members 
of a noncompliant patient resorted to a novel if 
unorthodox method for the administration of 
clozapine. 
CASE HISTORY 
Mr.S, a 30-year-old male, was brought with 
a 6-year history of delusions of persecution, 
auditory hallucinations, volatile mood swings, and 
deterioration in functional abilities. He had failed 
previous trials of haloperidol, pimozide, 
flupenthixol, and risperidone. These drugs had 
been given in adequate doses for adequate 
periods of time, and compliance had been 
ensured by the use of depot preparations of 
haloperidol and flupenthixol. Antidepressant and 
benzodiazepine drugs had also been 
unsuccessfully added to the medication regime 
at various points in time. 
The family refused a trial of 
electroconvulsive therapy. In view of the clear 
treatment-refractoriness, clozapine was advised. 
After approximately a month of treatment, by 
which time a dose of 200mg/day was attained, 
there was moderate attenuation of psychotic 
symptoms; however, the patient refused to 
continue treatment any further because he 
insisted that he had recovered completely and 
that he could remain well on will power alone. 
His family did not wish to lose the gains 
that had accrued with the introduction of 
clozapine. They therefore crushed the tablets and 
administered the powder in his food. However, 
despite the serving of the medication along with 
rice, fish curry, and other preparations, the 
patient perceived an odd taste in his meals. He 
began to suspect, and rightly so, that medication 
was being added to his food. He therefore insisted 
upon eating only chappatis as the staple element 
of his meals. 
As a last resort, the family administered 
the crushed and powdered tablets, nightly, along 
with scrambled eggs, with salt and pepper added 
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to taste. The strong taste of the egg, along with 
the spicing, effectively masked the taste of 
clozapine. 
One and a half years have elapsed since 
the inception of this novel method of 
administration of clozapine, and the patient 
continues to maintain the improvement that he 
had initially shown. 
DISCUSSION 
This case highlights four important issues: 
1.Scrambled egg, along with salt and pepper, 
effectively masks the taste of clozapine. This, 
therefore, is a practical method for the 
surreptitious administration of medication to a 
noncompliant patient. 
2. The above notwithstanding, it is unethical and 
illegal to treat a patient without his knowledge; 
this holds true even when the family members of 
the patient themselves undertake the 
responsibility for the act. Legally, an unwilling 
patient can be treated against his will only if 
committed to psychiatric care through 
appropriate judicial processes. 
3. It is particularly wrong to surreptitiously treat 
patients with clozapine because blood monitoring 
for granulocytopenia and agranulocytosis 
becomes difficult to effect. Current 
recommendations are that patients be monitored 
weekly for the initial 6 months, and once in two 
weeks thereafter (Physicians Desk Reference, 
1999). In the case of the present patient, the 
family took a calculated risk against medical 
advice, weighing the approximately 0.5% risk of 
agranulocytosis against the benefits afforded by 
clozapine. 
4. That the family readily obtained clozapine 
without a medical prescription is an damning 
indictment of the system of drug availability 
in the country. There is a pressing need for 
greater ethical practice amongst pharmaceutical 
dispensers. 
Interestingly, the surreptitious 
administration of clozapine has been reported 
from other countries as well (Pereira et al., 1999). 
The* practice of administering medication in food 
and drink may be widespread in settings such 
as long stay facilities for the elderly (Treolar et 
al., 2000). In this contest, Treolar et al. (2001) 
discussed ethical and related issues, and 
suggested recommendations on the subject. 
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REPETITIVE TATTOOING IN BORDERLINE 
PERSONALITY AND OBSESSIVE-
COMPULSIVE DISORDER 
Sir, 
Association of personality disorders with 
tattooing, though previously reported, is mostly 
limited to antisocial personality disorder (Raspa 
& Cusack, 1990). A case of repetitive tattooing, a 
kind of self-mutilatory behaviour, is described in a 
patient with borderline personality disorder with 
comorbid obsessive-compulsive disorder (OCD). 
A 52-year-old single white male was 
admitted to the Veteran's Administration Hospital, 
Pittsburgh, USA, with a history of obsessive-
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